Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
US Department of Justice
Accenture
Healthtrust
Julphar

Generated: March 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Rigosertib

« Back to Dashboard

US Patents for Rigosertib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Rigosertib ➤ Try a Free Trial Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders Temple University - Of the Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA) ➤ Try a Free Trial
Rigosertib ➤ Try a Free Trial Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones Onconova Therapeutics, Inc. (Newtown, PA) ➤ Try a Free Trial
Rigosertib ➤ Try a Free Trial Composition and methods for the treatment of proliferative diseases Temple University - Of The Commonwealth System of Higher Education (Philadelphia, PA) Mount Sinai School of Medicine (New York, NY) ➤ Try a Free Trial
Rigosertib ➤ Try a Free Trial Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis Temple University--Of The Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA) ➤ Try a Free Trial
Rigosertib ➤ Try a Free Trial Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones Temple University--Of The Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA) ➤ Try a Free Trial
Rigosertib ➤ Try a Free Trial Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones Onconova Therapeutics, Inc (Newtown, PA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Rigosertib

Drugname Country Document Number Estimated Expiration Related US Patent
Rigosertib Austria 525067 2022-02-28 ➤ Try a Free Trial
Rigosertib Australia 2003213660 2022-02-28 ➤ Try a Free Trial
Rigosertib Canada 2477232 2022-02-28 ➤ Try a Free Trial
Rigosertib Eurasian Patent Organization 008736 2022-02-28 ➤ Try a Free Trial
Rigosertib Eurasian Patent Organization 200401124 2022-02-28 ➤ Try a Free Trial
Rigosertib European Patent Office 1487428 2022-02-28 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
McKesson
UBS
Fuji
Merck
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.